Heart HealthNew Antibody Cocktail Offers Broad Protection Against All Ebola Virus Species
Ebola virus remains one of the deadliest infectious threats, with case fatality rates that can exceed 90%. This MedCram video by Dr. Roger Seheult covers the fundamentals of Ebola virus biology, with a focus on the Bundibugyo virus species (BDBV), which has fewer approved treatments than the more common Zaire strain. The most promising development highlighted is a two-antibody cocktail shown in a Cell study to provide broad therapeutic protection across multiple Ebola species in ferrets and nonhuman primates. A small San Diego biotech, Mapp Bio, is at the center of this effort as an ongoing epidemic worsens. Understanding emerging infectious disease treatments is directly relevant to global health resilience and personal risk awareness.
